Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alane Izu

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Vaccine|July 5, 2025
Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countriesClare L Cutland, Kimberley Gutu, Jessica Ann Yun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Potential of Minimally Invasive Tissue Sampling for Attributing Specific Causes of Childhood Deaths in South Africa: A Pilot, Epidemiological StudyRichard Chawana, Vicky Baillie, Alane Izu, et al.
The Journal of Infection|March 2, 2023
Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in BotswanaEmily Shava, Alane Izu, Tendani Gaolathe, et al.
Scientific Reports|March 7, 2025
Genomic relatedness of colonizing and invasive disease Klebsiella pneumoniae isolates in South African infantsCourtney P Olwagen, Alane Izu, Shama Khan, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 10, 2026
Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting reportLaurence de Moerlooze, Alexander Allen, Ilaria Bartalesi, et al.
IJID Regions|December 13, 2023
Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study - final study resultsJoseph Makhema, Emily Shava, Alane Izu, et al.
Human Vaccines & Immunotherapeutics|April 12, 2024
Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharidesKirsty Le Doare, Michelle A Gaylord, Annaliesa S Anderson, et al.
The New England Journal of Medicine|July 19, 2023
Potential for Maternally Administered Vaccine for Infant Group B StreptococcusShabir A Madhi, Annaliesa S Anderson, Judith Absalon, et al.
Open Forum Infectious Diseases|January 26, 2026
Genomic Characterization of <i>Klebsiella pneumoniae</i> Causing Invasive Disease in South African Infants: Observational Studies Between 2018 and 2023Courtney P Olwagen, Alane Izu, Shama Khan, et al.
Nature Immunology|June 15, 2023
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19Paulina Kaplonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Vaccine|July 5, 2025
Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countriesClare L Cutland, Kimberley Gutu, Jessica Ann Yun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Potential of Minimally Invasive Tissue Sampling for Attributing Specific Causes of Childhood Deaths in South Africa: A Pilot, Epidemiological StudyRichard Chawana, Vicky Baillie, Alane Izu, et al.
The Journal of Infection|March 2, 2023
Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in BotswanaEmily Shava, Alane Izu, Tendani Gaolathe, et al.
Scientific Reports|March 7, 2025
Genomic relatedness of colonizing and invasive disease Klebsiella pneumoniae isolates in South African infantsCourtney P Olwagen, Alane Izu, Shama Khan, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 10, 2026
Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting reportLaurence de Moerlooze, Alexander Allen, Ilaria Bartalesi, et al.
IJID Regions|December 13, 2023
Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study - final study resultsJoseph Makhema, Emily Shava, Alane Izu, et al.
Human Vaccines & Immunotherapeutics|April 12, 2024
Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharidesKirsty Le Doare, Michelle A Gaylord, Annaliesa S Anderson, et al.
The New England Journal of Medicine|July 19, 2023
Potential for Maternally Administered Vaccine for Infant Group B StreptococcusShabir A Madhi, Annaliesa S Anderson, Judith Absalon, et al.
Open Forum Infectious Diseases|January 26, 2026
Genomic Characterization of <i>Klebsiella pneumoniae</i> Causing Invasive Disease in South African Infants: Observational Studies Between 2018 and 2023Courtney P Olwagen, Alane Izu, Shama Khan, et al.
Nature Immunology|June 15, 2023
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19Paulina Kaplonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Pageof 8